ArticleBMC cancer2009

The cyclin-dependent kinase inhibitor 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole induces nongenotoxic, DNA replication-independent apoptosis of normal and leukemic cells, regardless of their p53 status.

Valentina Turinetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.